Download the Protocol

MGF

Mechano Growth Factor is a natural repair signal the body releases in muscles after stress or exercise. It tells nearby cells to start rebuilding and strengthening the muscle tissue. Researchers study it for its potential role in faster recovery, improved muscle growth, and protection against age-related muscle decline.

Description

• MGF, or Mechano Growth Factor, is a splice variant of the IGF-1 gene (IGF-1Ec) that is rapidly expressed after muscle stress or damage.
• It is considered a potent stimulator of local muscle repair and satellite cell activation.
• Research focuses on muscle hypertrophy, recovery, and age-related muscle loss.

How It Works

• MGF activates dormant muscle stem cells (satellite cells) to begin muscle regeneration.
• Promotes protein synthesis and local tissue repair independently of systemic IGF-1 signaling.
• Functions as an autocrine/paracrine peptide—acting locally at the site of muscle stress or micro-trauma.

Documented Effects

• Stimulates muscle fiber growth and regeneration following resistance training or injury in animal studies.
• Enhances muscle recovery and cellular proliferation in preclinical models.
• Shown to promote muscle satellite cell activation and differentiation.
• Supports anabolic repair processes following exercise-induced damage.

Theoretical Effects

• May contribute to improved muscle recovery and hypertrophy during resistance training.
• Potential use for age-related sarcopenia and injury rehabilitation research.
• No established human dosing standards or long-term safety data.

Pharmacokinetics

• Half-life: Very short; estimated minutes after injection.
• Time to peak activity: Rapid, within 10–30 minutes post-administration.
• Duration: Local effects last several hours; systemic clearance is rapid.

Reconstitution

• Use only bacteriostatic water for reconstitution.
• Example vial: 2 mg of MGF
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 0.2 mg (200 mcg) per 10 units
  • 2 mL water → 0.1 mg (100 mcg) per 10 units
• Swirl gently to dissolve—avoid vigorous shaking.
• Refrigerate reconstituted solution (2–8 °C). Use within ~14 days for best stability.

Injectable Dosage Overview (Research Reference)

Typical Starting Dose

• Experimental protocols often begin at ~100–200 mcg intramuscular (IM) or subcutaneous (SC) per site, 2–3× per week.
• Conservative entry point: 100 mcg per site to gauge local tissue response.

Common Research Range

• Typically 200–400 mcg per injection site, up to 3× per week following training or muscle trauma.
• Localized administration near target muscle is standard in experimental setups.
• Sometimes alternated or paired with IGF-1 LR3 in sequential protocols (MGF post-workout, IGF-1 next day).

Maximum Daily Dose

• No formal limit established; total weekly exposure generally kept below 1–2 mg in studies.
• Higher frequencies not supported by published data and may reduce efficacy through receptor desensitization.

Standard Cycle Length

• Short cycle: 4–6 weeks continuous exposure.
• Extended use: 8 weeks followed by 4 weeks off to assess results before resuming.

Clinical Notes

• Inject intramuscularly close to the trained or injured muscle group.
• MGF is short-lived; timing post-exercise is key in experimental settings.
• Do not mix with IGF-1 in the same syringe; use separate administrations.
• Stable for about 14 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes

• Human trials are limited; effects based primarily on animal and in-vitro research.
• Injection site irritation is the most commonly reported side effect.
• Use sterile technique and ensure laboratory-verified peptide quality.
• Not approved for therapeutic human administration; for research use only.